Carbon Biosciences Launches with $38 Million Series A Financ

Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline

BOSTON--(BUSINESS WIRE)--Jun 21, 2022--

Related Keywords

Massachusetts , United States , Philadelphia , Pennsylvania , University Of Massachusetts , Mariesa Kemble , Robertm Kotin , Derek Yoon , Geeta Vemuri , Chen Schor , David Steinberg , Jianming Qiu , Royj Carver , Beverly Davidson , Ziying Yan , Robert Kotin , John Engelhardt , Johnf Engelhardt , Adicet Bio , Joel Schneider , Sebastian Aguirre , Lucy Liu , Adrian Thrasher , University Of Kansas , Linkedin , University Of Iowa , Partners At Longwood Fund , University Of Massachusetts Chan Medical School , Cystic Fibrosis Foundation , University Of Tokyo Innovation Platform Utokyo , Astellas Venture Management , Professor At University College London , Longwood Fund , Institute Of Child Health , Craniofacial Research , Solasta Ventures , Tokyo Innovation Platform , Gene Therapy , Physiological Systems , Massachusetts Chan Medical , Carbon Biosciences , Business Wire , Managing Partner , Molecular Medicine , Scientific Advisory Board , Senior Investigator , Chief Scientific Strategy Officer , University College London , Great Ormond Street Institute , Child Health , Clinical Gene Therapy , Adicet Bio President , Pyxis Oncology , Tome Bio , Agent Capital , Money , Ational ,